ANI Pharmaceuticals, Inc. ( ANIP) - Key Metrics

ANIP Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q1 ? ? ? ?
2025Q4 $12.32 $1.37 $1.51 $0.32
2025Q3 $11.35 $1.20 $2.19 $1.89
2025Q2 $10.66 $0.43 $3.82 $3.47
2025Q1 $10.05 $0.80 $1.78 $0.77

ANIP Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q1 ? ?
2025Q4 ? 14.40
2025Q3 1.43% 19.05
2025Q2 4.76% 37.85
2025Q1 2.59% 20.93

ANIP Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q1 3.25% ?
2025Q4 0.41% ?
2025Q3 2.06% 0.02%
2025Q2 5.32% 0.03%
2025Q1 1.15% 0.03%

ANIP

Price: $79.20

52 week price:
56.71
99.50

Payout Ratio Range:
-17.80%
35.15%

Earnings Per Share: 3.91 USD

P/E Ratio: 20.35

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 67658

Ebitda: 16.4 million

Market Capitalization: 1.8 billion

Links: